C84.99

Clinical Causes: Infections, such as Epstein-Barr virus (EBV) or human T-cell lymphotropic virus (HTLV-1), which can increase lymphoma risk. Genetic mutations or alterations in immune cells that lead to uncontrolled growth. Prolonged exposure to certain chemicals or pesticides. Immunodeficiency conditions, including HIV/AIDS, which compromise immune system defenses. Previous cancer treatments like chemotherapy or radiation therapy.

Key Symptoms: Swelling or a lump in the affected area, such as skin or organs. Unexplained weight loss and fatigue. Fever that persists without an obvious cause. Night sweats, often severe enough to soak clothing. Abdominal pain or swelling if the gastrointestinal tract is involved. Skin lesions, rashes, or ulcers when the skin is affected. Shortness of breath or cough if the lungs are involved.

Diagnosis Path: Physical examination to assess swelling, skin changes, or organ enlargement. Imaging tests such as CT (computed tomography) scans or PET (positron emission tomography) scans to locate and evaluate the extent of the disease. Biopsy, which involves removing a tissue sample from the affected area for microscopic examination to confirm lymphoma type. Laboratory tests, including bloodwork to check for abnormalities or markers associated with lymphoma. Immunophenotyping and molecular studies to determine specific cell markers and genetic features, aiding in precise classification.

Treatment Protocols: Chemotherapy, often combined with targeted therapies to kill cancer cells. Radiation therapy to target localized tumor sites, especially for skin or organ involvement. Stem cell transplants in certain cases where aggressive treatment is necessary. Immunotherapy approaches to boost the body’s natural defenses against cancer. Supportive care, such as managing symptoms and preventing complications like infections.